Trading Signals: IMV Stock Price Prediction and Forecast (Thu. Dec. 7, 2017 - Tue. Sep. 15, 2020)(IMV Inc.)
| IMV latest price $5.7400 (7.09%) ($5.1900 - $5.8600) on Mon. Dec. 18, 2017. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 4.52% (three month average) | | RSI | 76 | | Latest Price | $5.7400(7.09%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | IMV advances 1.6% a day on average for past five trading days. | | Weekly Trend | IMV advances 11.3% a week on average for past two weeks. | | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | | Correlated ETFs | Broad market will support IMV advance at 0% a week (0% probability)
EMHY(11%) LIT(11%) XOP(11%) BOTZ(10%) XAR(10%) | | Factors Impacting IMV price | IMV will decline at least -2.26% in a week (0% probabilities).
VIXM(-10%) GLD(-10%) VCSH(-9%) VCIT(-9%) GDX(-7%) | | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | | | | Relative Volatility | | | | | | Market Trend Strength | -2.26% (StdDev 4.52%) | | Hourly BBV | 0 () | | Intraday Trend | 10.6% | | | | | |
|
| 5 Day Moving Average | $5.25(9.33%) | | 10 Day Moving Average | $5.17(11.03%) | | 20 Day Moving Average | $4.67(22.91%) | | To recent high | 0% | | To recent low | 14.6% | | Market Cap | $354m | | | | | | |
IMV, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of immunotherapies for the treatment of infectious diseases. Its proprietary drug delivery platform DPX develops a pipeline of novel therapeutic and preventive approaches for cancer and other serious diseases. The company was founded by Warwick Kimmins and Brian E. Lowe on March 28, 2000 and is headquartered in Dartmouth, Canada.July 14, 2020 IMV (NASDAQ:IMV) announced Health Canada sign-off on a Phase 1 study of its candidate DPX-COVID-19, expected to launch this summer. Shares are up a healthy 153% premarket on robust volume. |